Updates are available Addendum dated 2025-01-30
Click to view Addendum: https://doi.org/10.1038/s41559-025-02640-8
Updates are available Correction dated 2025-01-30
Click to view Correction: https://doi.org/10.1038/s41559-025-02641-7
-
Authors
Serrano, Isabel M. https://orcid.org/0009-0007-2760-0742
Hirose, Misa https://orcid.org/0000-0002-8909-4693
Valentine, Charles C. https://orcid.org/0000-0001-5630-7368
Roesner, Sharon
Schmidt, Elizabeth
Pratt, Gabriel
Williams, Lindsey
Salk, Jesse https://orcid.org/0000-0002-7804-0550
Ibrahim, Saleh https://orcid.org/0000-0001-7827-2290
Sudmant, Peter H. https://orcid.org/0000-0002-9573-8248
-
Funding
Funding for this research was provided by:
Vallee Foundation (N/A)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM142916)
NSF | Directorate for Education & Human Resources | Division of Graduate Education (1752814)
NSF | Directorate for Education & Human Resources | Division of Graduate Education (2146752)
Ford Foundation (N/A)
- License Information
-
More Information
Article History
Received: 8 March 2023
Accepted: 22 January 2024
First Online: 15 February 2024
Change Date: 30 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41559-025-02641-7
Competing interests
: C.C.V., S.R., E.S., G.P., L.W. and J.S. declare they are equity holders of TwinStrand Biosciences, Inc. Additionally, C.C.V., E.S. and J.S. are current employees of TwinStrand Biosciences, and C.C.V., E.S., L.W. and J.S. are inventors on one or more duplex sequencing-related patents. All other authors declare no competing interests.
